does in Biological Technology

BASF Podcast: The Chemical Reporter - Why Does Your Urine Smell so Different After You've Eaten Asparagus?

LUDWIGSHAFEN, Germany, June 10 /PRNewswire/ -- It doesn't take long after you've polished off a plateful of the delicious vegetable before you are forcefully reminded of it in the restroom. Some people are surprised by the strange odor rising from the bowl after urinating. The unmistakable olf...

Clinical Pharmacology Study With AZILECT(R) (Rasagiline Tablets) Demonstrated It Does Not Increase Tyramine Sensitivity

Study Indicated Rasagiline Selectivity for Inhibiting MAO-B at Maximum Approved Dose KANSAS CITY, Mo., June 9 /PRNewswire/ -- Teva Neuroscience, Inc. today presented results from a clinical pharmacology study in which AZILECT(R) (rasagiline tablets) did not increase the risk of tyramine sensi...

Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid

CORONA, Calif., March 31 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, announced today that the United States District Court for the District of Delaware has ruled that Watson's generic version of Concerta (methylphenidate hydroc...

New Technology to Revolutionize the Way the Planet Does Business

Innovative Company Makes it Possible for Employers to Hire Overseas Workers - Even for Domestic Manual Labor LOS ANGELES, March 16 /PRNewswire/ -- Today's outsourcing industry has taken a giant leap forward thanks to new, revolutionary technology created by Cybracero Systems ( http://www.cy...

Stenum Hospital Does its 600th American Disc Replacement Surgery

October, 2008, Stenum Hospital, Germany, just five years after Jim Rider, the first American patient to receive disc replacement at Stenum Hospital, has now surpassed the 600 American patient milestone. Bremen, Germany (PRWEB) October 24, 2008 -- With the growing health...

New nanotechnology television series does 'sweat the small stuff'

The Project on Emerging Nanotechnologies (PEN) and National Science Foundation (NSF) will host the Washington, DC, premiere event for the television series Nanotechnology: The Power of Small on Wednesday evening, April 2. The eventby invitation onlywill include remarks by U.S. Senator Ron Wyden (D...

Where does stored nuclear waste go?

Millions of gallons of hazardous waste resulting from the nations nuclear weapons program lie in a remote location in southeastern Washington state called Hanford. Beneath this desert landscape about two million curies of radioactivity and hundreds of thousands of tons of chemicals are captured w...

IT Does Matter!

The controversial May edition of the Harvard Business Review (HBR), containing an article written by Nicholas Carr entitled IT Doesn't Matter , questioned the impact of IT investments. This has created a stir in the business and technology communities. One of the dissenters of Carrs article is PR...

Pushing the Fast-Forward Button on Networking Does It Work?

EAU CLAIRE Lets face it, not all technologists are the life of the party. As much as theyre generally brilliant in their respective fields and even visionary in how they transfer ideas to the marketplace, group dynamics and networking isnt often their strength. In fact, theres even a joke to reinf...

Who does your IT staff work for?

You probably know who signs the paychecks in your organization. Most of us can read an organization chart and figure out who reports to whom. We might even know one or two board members, shareholders or major contributors. But that might not tell you much about who your IT staff is really working f...

How Good Does Your Web Site Look on Paper?

The best way to ensure the effectiveness of your companys next web site is to let the sites users lend you a hand (quite literally) through the process of paper prototyping. Paper prototyping is a fast, low-cost method of testing web site designs. It involves creating rough sketches of a web sit...

Curious customer service: When a help desk does it right

Printers are the mules of the 21st century. They carry incredible burdens of intellectual capital if page counts are any indication, and they have the same bulky, intractable personalities attributed in story and lore to their four-legged forbearers. Last week I ran into the second characteristic...

IT - Does everybody get a vote?

Madison, Wis. Sir Winston Churchill was once quipped, "Democracy is the worst form of government except all the others that have been tried." Certainly one of the challenges of democracy is that it encourages a confusion of popularity with leadership, and this poses a dilemma for conducting b...

What does business want from the schools? Some answers may be surprising

Madison, Wis. - More math? Sure. Science literacy? Of course. Exposure to foreign languages? Yes. Those skills represent part of what Wisconsin business leaders want to see in graduates of the state's K-12, technical college, and university systems. However, a set of attributes loosely desc...

RNAi: Size Does Matter

Everyone wants to design the dsRNA that most efficiently silences the gene of interest. But how does dsRNA length correlate with silencing efficiency? Ambion scientists addressed this question in the following experiment. ...

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

...low (the "Reporting Persons"), that the stockholder action by written consent purported to have been taken by such Reporting Persons on August 5, 2009 does not comply with the requirements of the Company's By-Laws and is therefore invalid and not effective. Specifically, on August 5, 2009, the Repo...

Schering-Plough Shareholders Approve Merger With Merck

...re are no guarantees about the performance of Schering-Plough stock or Schering-Plough's business or the combined company's business. Schering-Plough does not assume the obligation to update any forward-looking statement. A number of risks and uncertainties could cause actual results to differ ma...

Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading

... MD, Professor of Anesthesiology at MD Anderson in Houston, one of the foremost experts on vertebroplasty, stated, "The conclusion that vertebroplasty does not help back pain is completely wrong. If you look closely at the study design, what they are calling a placebo is actually a facet injection." ...

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

...s filings with the SEC are available from the SEC, may be found on the Company's website or may be obtained upon request from the Company. The Company does not undertake any obligation to update the information contained herein, which speaks only as of this date. ...

Synthetech Reports First Quarter Fiscal 2010 Results

...uncertainties not presently known to Synthetech or which Synthetech currently deems immaterial also may impair its business or operations. Synthetech does not intend to release publicly any revisions to any forward-looking statements contained herein to reflect events or circumstances after the date here...

Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services

...s, intentions and the like, which involve assumptions regarding the Company's operations and conditions in the markets the Company serves. The Company does not undertake any obligation to update these forward-looking statements. Sigma-Aldrich is a registered trademark and Discovery(CPR) is a trade...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...e for the treatment of idiopathic pulmonary fibrosis (IPF), which InterMune does not promote. Research and development (R&D) expenses in the se...ower off-label sales of Actimmune for the treatment of IPF, which InterMune does not promote. Revenue from the collaboration with Roche was $1.6 million in...

Telik Announces Second Quarter 2009 Financial Results

... Telik's commercial opportunity will be reduced or eliminated, and if Telik does not obtain regulatory approval to market products in the U.S. and foreign c...ded December 31, 2008 and subsequent quarterly reports on Form 10-Q. Telik does not undertake any obligation to update forward-looking statements contained...

Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval

... CTI had approximately $12.0 million in cash and cash equivalents, securities available-for-sale, and interest receivable as of June 30, 2009. This does not include approximately $41.7 million, net of underwriting discount, the Company received in July 2009 in connection with an underwritten offering o...

New clues about a hydrogen fuel catalyst

...th additional experimental data, allowed the team to outline the chemical reaction occurring between the catalyst and the ammonia borane. The catalyst does not remain still, said Rousseau, making it a good catalyst but, like an active two-year old, also a difficult subject to pin down. Plucking Atoms ...

ADVENTRX Pharmaceuticals Announces Financing

....gov . You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date when made. ADVENTRX does not intend to update any forward-looking statement as set forth in this press release to reflect events or circumstances arising after the date on whi...

GeoVax Labs, Inc. Provides Clinical Studies Update

...an GeoVax's products, and other factors over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. Certain matters discussed in this news release are forward-looking statements involving certain risks and uncertainties including...

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

...tements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2008. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements. Contact: Noelle Boyd Richard M....

Cord Blood America Retires $2.53M Obligation

...ould not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, ev...

Pharmacy Compounds Liquid Mupirocin for the Chronic Sinusitis Patient

... Liquid. Mupirocin is typically only found in ointment form. ASL's compound does not contain any added ingredients, only pure mupirocin, sterile water and s...table for nasal irrigation or inhalation. ASL's compounded mupirocin liquid does not contain the other ingredients found in the ointment. ASL's formula only...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

...ay not be useful or cost-effective for formulation into products; Senomyx's ability to compete in the flavor ingredients market may decline if Senomyx does not adequately protect its proprietary technologies; and the current economic environment may negatively impact Senomyx's ability to establish new col...

Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure

... 2008 filed with the Securities and Exchange Commission on March 12, 2009. Nile is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise. ...

ETC Biomedical Announces Chamber Sale in India

... The Company cautions that the foregoing list of important factors is not exclusive. Except as required by federal securities law, the Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company. ...

Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials

...nties. A number of important factors could cause actual results to differ materially from those contained in any forward- looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law. For more information, please co...

Five Questions About Protopic (tacrolimus) Ointment

...opic Ointment only on areas of skin that have eczema Not use Protopic Ointment on a child under 2 years old(12) If the eczema does not improve within six weeks, patients should contact their doctor. Visit www.protopic.com for more information including full prescribing ...

SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS

...es of Sweet Enhancers developed under the collaboration. This new agreement does not impact Senomyx's existing collaborations with other companies on its Sw... ability to compete in the flavor ingredients market may decline if Senomyx does not adequately protect its proprietary technologies. These and other risks ...

Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials

...ainties. A number of important factors could cause actual results to differ materially from those contained in any forward- looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law. For more information, please co...

AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma

...sks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of ...

Yongye International Announces Branded Store Network Increases Over 40% to 5,000 Stores

...ce for many years and sell a variety of agricultural input products. Yongye does not execute any direct agreements with the store owners and the distributor...risk factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements. For m...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

...y future in-licensing, collaborations, acquisitions, mergers, dispositions, joint ventures, or investments Transcept may enter into or make. Transcept does not assume any obligation to update any forward-looking statements, except as required by law. Contacts: Purdue Pharma L.P. ...